An exclusive AMCP member resource offering key charts, data points, and insights from the annual Access, Affordability, and Outcomes report, perfect for quick reference and sharing essential managed care pharmacy trends.
AMCP Comments on PREVENT HPV Cancers Act
In today’s fast-changing health care environment, AMCP provides the tools and information you need to understand the issues and how they affect you and the patients you serve.
In its second year, AMCP's annual Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy 2024 report looks at the fundamental concepts of managed care pharmacy and provides insight and clarity into how today's changing health care climate can be navigated to improve patient care and outcomes.
View the 2024 AAO Report to learn how managed care pharmacy professionals facilitate appropriate access to prescription treatments and promote affordability to help improve outcomes for patients across America’s health care system.
On October 2, 2024, the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services (HHS) issued the Final Guidance for the Second Cycle of the Historic Medicare Drug Price Negotiation Program for Fiscal Year 2027.
On Oct. 1, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a set of frequently asked questions (FAQs) related to the Medicare Prescription Payment Plan.
On September 30, 2024, the Centers for Medicare and Medicaid Services (CMS) issued a Decision Memo titled “Final National Coverage Determination (NCD) for Pre-Exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Prevention”
On Sept. 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a final rule on the Medicare Drug Rebate Program (MDRP). Access the Regulatory NewsBREAK to learn more.
